Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 2,613 | 0.0% | 39,365 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,268 | 0.0% | 36,775 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 530 | 0.0% | 33,517 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 428 | 0.0% | 33,596 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 632 | 0.0% | 33,606 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 586 | 0.0% | 30,262 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 747 | 0.0% | 28,739 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 681 | 0.0% | 23,812 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 695 | 0.0% | 22,699 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 611 | 0.0% | 22,742 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 682 | 0.0% | 19,118 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 451 | 0.0% | 17,739 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 600 | 0.0% | 14,801 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 437 | 0.0% | 13,219 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 465 | 0.0% | 13,219 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 610 | 0.0% | 13,258 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 974 | 0.0% | 14,690 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 683 | 0.0% | 10,947 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 908 | 0.0% | 10,958 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 768 | 0.0% | 11,582 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 914 | 0.0% | 11,911 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 475 | 0.0% | 11,033 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 477 | 0.0% | 11,033 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 236 | 0.0% | 8,218 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 362 | 0.0% | 5,701 | 12/31/2019 |